Jefferies Downgrades Moonlake Immunotherapeutics (MLTX) to Hold, 'Growing Uncertainty in SLK Path Fwd and Dimmed Commercial Outlook'

Go back to Jefferies Downgrades Moonlake Immunotherapeutics (MLTX) to Hold, 'Growing Uncertainty in SLK Path Fwd and Dimmed Commercial Outlook'
(NASDAQ: MLTX) Delayed: 17.49 --0 (-0%)
Previous Close $17.49    52 Week High
Open $17.49    52 Week Low
Day High $17.49    P/E N/A 
Day Low $17.49    EPS
Volume 1,223